望隼 4771
Listed · Biotechnology and medical care180▼-1 (-0.55%)After close
- Prev close
- 181
- Volume (shares)
- 225,682
- Data time
- 2026-11-11 13:30:00
- Open
- 181.50
- High
- 183.50
- Low
- 179.50
- Prev close
- 181.00
- Volume (lots)
- 226
- Turnover
- 0.41 億
- P/E
- 11.9
- Cash yield
- 3.87%
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 43.46% | 40.99% | 41.32% | 40.01% | 40.77% | 41.43% | 40.35% | 37.30% |
| Operating margin | 30.95% | 28.92% | 29.12% | 27.47% | 29.36% | 29.42% | 29.13% | 27.63% |
| Net margin | 25.88% | 23.43% | 24.15% | 24.77% | 18.98% | 24.84% | 23.93% | 21.18% |
| ROE (TTM) | 23.39% | 19.05% | 19.71% | 19.89% | 19.65% | 19.54% | 25.17% | 27.49% |
| ROA (TTM) | 13.66% | 12.31% | 12.43% | 12.34% | 11.45% | 12.35% | 14.02% | 15.06% |
| EPS, quarter (TWD) | 4.74 | 3.66 | 3.51 | 3.30 | 2.58 | 3.32 | 2.92 | 2.48 |
| EPS, TTM (TWD) | 15.21 | 13.05 | 12.71 | 12.12 | 11.30 | 11.71 | 11.81 | 12.17 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-09 | 3.9 | -9.70% | 24.89% | 33.7 | 32.97% |
| 2026-08 | 4.4 | 38.89% | 70.64% | 29.8 | 34.12% |
| 2026-07 | 3.1 | -20.34% | 11.68% | 25.4 | 29.36% |
| 2026-06 | 3.9 | 3.64% | 31.26% | 22.3 | 32.32% |
| 2026-05 | 3.8 | -9.32% | 33.13% | 18.3 | 32.55% |
| 2026-04 | 4.2 | 20.71% | 47.26% | 14.5 | 32.40% |
| 2026-03 | 3.5 | 10.61% | 18.16% | 10.3 | 27.17% |
| 2026-02 | 3.1 | -14.48% | 21.32% | 6.8 | 32.31% |
| 2026-01 | 3.7 | 27.93% | 43.41% | 3.7 | 43.41% |
| 2025-12 | 2.9 | -6.62% | 29.17% | 34.9 | 16.17% |
| 2025-11 | 3.1 | -13.32% | 35.04% | 32.0 | 15.13% |
| 2025-10 | 3.6 | 12.48% | 14.25% | 28.9 | 13.35% |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.0 | 10.3 | 9.5 | 8.5 | 8.7 | 8.1 | 7.6 | 7.4 |
| Cost of revenue | 6.8 | 6.1 | 5.6 | 5.1 | 5.2 | 4.7 | 4.5 | 4.7 |
| Gross profit | 5.2 | 4.2 | 3.9 | 3.4 | 3.6 | 3.4 | 3.1 | 2.8 |
| Operating expenses | 1.5 | 1.2 | 1.2 | 1.1 | 1.0 | 1.0 | 0.9 | 0.7 |
| Operating income | 3.7 | 3.0 | 2.8 | 2.3 | 2.6 | 2.4 | 2.2 | 2.1 |
| Non-operating items | 0.1 | 0.1 | 0.2 | 0.3 | -0.7 | 0.2 | 0.1 | -0.0 |
| Pre-tax income | 3.8 | 3.1 | 3.0 | 2.7 | 1.8 | 2.6 | 2.3 | 2.0 |
| Income tax | 0.7 | 0.7 | 0.7 | 0.6 | 0.2 | 0.5 | 0.5 | 0.5 |
| Continuing operations | 3.1 | 2.4 | 2.3 | 2.1 | 1.7 | 2.0 | 1.8 | 1.6 |
| Net income | 3.1 | 2.4 | 2.3 | 2.1 | 1.7 | 2.0 | 1.8 | 1.6 |
| Net income to parent | 2.8 | 2.1 | 2.1 | 1.9 | 1.5 | 1.9 | 1.7 | 1.4 |
| Net income to NCI | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| Other comprehensive income | 0.2 | 0.5 | 0.8 | 0.6 | -1.6 | 0.3 | -0.1 | 0.2 |
| Total comprehensive income | 3.3 | 2.9 | 3.1 | 2.7 | 0.1 | 2.3 | 1.7 | 1.8 |
| EPS (TWD) | 4.74 | 3.66 | 3.51 | 3.30 | 2.58 | 3.32 | 2.92 | 2.48 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 27.2 | 26.6 | 26.6 | 26.4 | 26.1 | 26.5 | 24.3 | 22.6 |
| Non-current assets | 54.4 | 47.8 | 44.0 | 38.9 | 37.6 | 36.9 | 35.1 | 35.3 |
| Total assets | 81.6 | 74.4 | 70.6 | 65.3 | 63.7 | 63.4 | 59.4 | 57.9 |
| Current liabilities | 16.2 | 10.4 | 10.4 | 8.3 | 12.2 | 8.7 | 8.1 | 7.8 |
| Non-current liabilities | 19.3 | 16.9 | 16.1 | 16.1 | 13.2 | 13.5 | 12.8 | 13.3 |
| Total liabilities | 35.5 | 27.3 | 26.5 | 24.4 | 25.4 | 22.2 | 20.9 | 21.2 |
| Share capital | 5.9 | 5.9 | 5.9 | 5.9 | 5.8 | 5.8 | 5.8 | 5.8 |
| Capital surplus | 18.7 | 18.6 | 18.5 | 18.5 | 18.5 | 18.4 | 18.3 | 18.3 |
| Retained earnings | 16.0 | 17.3 | 15.2 | 13.1 | 11.2 | 12.9 | 11.0 | 9.3 |
| Other equity | 0.9 | 0.7 | 0.3 | -0.3 | -0.8 | 0.4 | 0.2 | 0.3 |
| Equity to parent | 41.4 | 42.5 | 39.8 | 37.2 | 34.8 | 37.6 | 35.3 | 33.7 |
| Non-controlling interests | 4.7 | 4.6 | 4.2 | 3.8 | 3.5 | 3.7 | 3.2 | 3.1 |
| Total equity | 46.1 | 47.1 | 44.1 | 41.0 | 38.2 | 41.3 | 38.5 | 36.7 |
| Book value per share (TWD) | 70.52 | 72.41 | 68.08 | 63.52 | 59.50 | 64.72 | 60.94 | 58.13 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.5 | 3.2 | 2.6 | 2.4 | 2.6 | 3.2 | 3.3 | 1.6 |
| Investing cash flow | -4.7 | -4.2 | -4.3 | -2.9 | -2.3 | -3.1 | -1.8 | -4.6 |
| Financing cash flow | 2.0 | 0.3 | -0.6 | -0.5 | 0.1 | 0.9 | -0.7 | -2.5 |
| FX effect | 0.1 | 0.2 | 0.4 | 0.3 | -0.8 | 0.1 | -0.0 | 0.1 |
| Net change in cash | 1.0 | -0.5 | -1.9 | -0.7 | -0.5 | 1.1 | 0.7 | -5.4 |
| Cash, beginning | 9.9 | 9.9 | 11.8 | 11.8 | 11.8 | 11.8 | 8.0 | 8.0 |
| Cash, ending | 10.4 | 9.4 | 9.9 | 11.8 | 12.5 | 12.9 | 11.8 | 11.1 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 168.13% | — | — | — | — | — | — | — |
| Debt ratio | 43.45% | 36.64% | 37.57% | 37.28% | 39.95% | 34.97% | 35.19% | 36.55% |
| Equity ratio | 56.55% | 63.36% | 62.43% | 62.72% | 60.05% | 65.03% | 64.81% | 63.45% |
| Equity multiplier | 1.77 | 1.58 | 1.60 | 1.59 | 1.67 | 1.54 | 1.54 | 1.58 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.55 | 0.54 | 0.54 | 0.54 | 0.52 | 0.51 | 0.58 | 0.61 |
| Equity turnover | 0.96 | 0.84 | 0.84 | 0.85 | 0.87 | 0.80 | 1.02 | 1.10 |
Source: MOPS. For reference only; not investment advice.